KVUE · XBRL financial data

Kenvue financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal quarters (KVUE's year ends in late December)

In millions of dollars	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 29, 2024	Q4 FY24Dec 29, 2024	Q1 FY25Mar 30, 2025	Q2 FY25Jun 29, 2025	Q3 FY25Sep 28, 2025	Q4 FY25Dec 28, 2025	Q1 FY26Mar 29, 2026	Q2 FY26Jun 28, 2026	Q3 FY26Sep 27, 2026
Revenue from contracts with customers	3,666	3,894	4,000	3,899	3,662*	3,741	3,839	3,764	3,780*	3,909	3,955	3,886
Cost of goods and services sold	1,623*	1,652	1,635	1,617	1,592*	1,573	1,578	1,538	1,643*	1,607	1,654	1,572
Gross profit	2,043	2,242	2,365	2,282	2,070*	2,168	2,261	2,226	2,137*	2,302	2,301	2,314
Research and development	133*	100	105	97	106*	99	91	94	98*	84	94	96
Selling, general and administrative	1,586*	1,573	1,641	1,590	1,525*	1,537	1,504	1,512	1,535*	1,453	1,537	1,569
Other operating income (expense)	3*	(78)	(12)	(7)	3*	(13)	(5)	(1)	42*	(11)	(6)	(6)
Operating income (loss)	460*	550	154	654	483*	558	692	629	535*	767	699	706
Interest expense	96*	109	106	108	108*	107	107	107	109*	106	103	104
Other income (expense)	0*	(1)	3	(1)	3*	0	1	10	(1)*	—	1	0
Income tax expense (benefit)	30	131	7	194	53*	136	168	128	97*	198	142	179
Net income (loss)	327	296	58	383	293*	322	420	398	330*	474	456	430
Earnings per share, basic USD per share	0.17	0.15	0.03	0.20	0.15*	0.17	0.22	0.21	0.17*	0.25	0.24	0.22
Earnings per share, diluted USD per share	0.17	0.15	0.03	0.20	0.15*	0.17	0.22	0.21	0.17*	0.25	0.24	0.22
Weighted average shares, basic millions of shares	1,915*	1,915	1,915	1,915	1,915*	1,914	1,919	1,918	1,917*	1,918	1,920	1,921
Weighted average shares, diluted millions of shares	1,927*	1,920	1,920	1,924	1,928*	1,925	1,928	1,923	1,920*	1,922	1,923	1,926

Balance sheet

CSV

Fiscal quarters (KVUE's year ends in late December)

In millions of dollars	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 29, 2024	Q4 FY24Dec 29, 2024	Q1 FY25Mar 30, 2025	Q2 FY25Jun 29, 2025	Q3 FY25Sep 28, 2025	Q4 FY25Dec 28, 2025	Q1 FY26Mar 29, 2026	Q2 FY26Jun 28, 2026	Q3 FY26Sep 27, 2026
Cash and cash equivalents	1,382	1,155	1,014	1,057	1,070	1,057	1,070	1,139	1,062	1,075	1,110	1,039
Accounts receivable	2,073	2,160	2,240	2,394	2,165	2,312	2,331	2,416	2,382	2,501	2,476	2,504
Inventory	1,851	1,884	1,849	1,820	1,591	1,680	1,776	1,794	1,666	1,674	1,722	1,815
Prepaid and other current assets	567	645	557	460	494	505	525	531	432	410	450	410
Total current assets	6,138	6,097	5,881	5,941	5,525	5,710	5,854	6,032	5,697	5,795	5,899	5,939
Property and equipment, net	2,042	2,005	2,004	1,776	1,849	1,927	2,038	2,092	2,212	2,208	2,226	2,233
Right-of-use asset	139	140	123	122	111	—	—	—	151	—	—	—
Goodwill	9,271	9,032	8,973	9,297	8,843	9,136	9,486	9,441	9,509	9,376	9,265	9,251
Total assets	27,851	27,283	26,443	26,925	25,601	26,257	27,132	27,248	27,076	26,854	26,735	26,671
Accounts payable	2,489	2,602	2,437	2,274	2,254	2,332	2,568	2,445	2,473	2,533	2,577	2,685
Accrued liabilities	1,456	1,083	1,262	1,164	1,132	1,007	1,081	958	1,159	901	1,040	1,522
Commercial paper	600	769	670	890	800	1,680	800	1,160	700	1,586	1,405	1,120
Current portion of long-term debt	0	750	750	750	750	749	749	750	750	0	0	0
Total current liabilities	5,481	6,166	5,937	5,946	5,739	6,666	5,988	6,156	5,945	5,896	5,867	6,216
Lease liability, non-current	97	98	88	86	76	76	96	98	107	99	92	94
Total liabilities	16,640	16,662	16,265	16,281	15,933	16,204	16,402	16,614	16,311	16,246	16,182	16,509
Retained earnings (accumulated deficit)	429	342	17	7	(93)	(163)	(136)	(136)	(204)	(128)	(70)	(447)
Total stockholders' equity	11,211	10,621	10,178	10,644	9,668	10,053	10,730	10,634	10,765	10,608	10,553	10,162
Total liabilities and equity	27,851	27,283	26,443	26,925	25,601	26,257	27,132	27,248	27,076	26,854	26,735	26,671
Common shares outstanding (cover page) millions of shares	1,915	1,915	1,915	1,917	1,911	1,920	1,919	1,916	1,917	1,920	1,921	1,922

Cash flows

CSV

Fiscal quarters (KVUE's year ends in late December)

In millions of dollars	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 29, 2024	Q4 FY24Dec 29, 2024	Q1 FY25Mar 30, 2025	Q2 FY25Jun 29, 2025	Q3 FY25Sep 28, 2025	Q4 FY25Dec 28, 2025	Q1 FY26Mar 29, 2026	Q2 FY26Jun 28, 2026	Q3 FY26Sep 27, 2026
Net income (loss)	327	296	58	383	293*	322	420	398	330*	474	456	430
Stock-based compensation	113*	81	61*	58*	54*	44	37*	25*	30*	29	32*	29*
Depreciation and amortization	174*	149	141	182	150*	136	142	141	138*	143	145*	143*
Net cash from operating activities	950*	287	440*	249*	793*	428	621*	294*	854*	489	688*	700*
Purchases of property and equipment	223*	153	90*	59*	132*	179	88*	98*	110*	139	64*	80*
Net cash from investing activities	(265)*	(152)	(85)*	(56)*	(132)*	(167)	(90)*	(104)*	(75)*	(167)	(78)*	(79)*
Share repurchases	7*	91	0*	23*	121*	63	64*	70*	0*	0	0*	0*
Dividends paid	383*	383	383*	393*	393*	392	393*	398*	398*	398	398*	403*
Net cash from financing activities	(383)*	(326)	(490)*	(162)*	(587)*	(310)	(548)*	(110)*	(869)*	(295)	(587)*	(679)*
Net change in cash	320*	(227)	(141)*	43*	13*	(13)	13*	69*	(77)*	13	35*	(71)*

Compare with peers

SIC 2844 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 2844 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.

Company	Cash ($M)	Revenue, quarter ($M)	Operating cash flow, quarter ($M)	Shares outstanding	Quarter
Kenvue	1,039	3,886	700*	1.9B	Q3 FY26 10-QSep 27, 2026
Estee Lauder Companies	3,198	3,715	(166)	not reported	Q1 FY27 10-QSep 30, 2026
Ecolab	722	4,695	764*	280.5M	Q3 FY26 10-QSep 30, 2026
Church & Dwight	447	1,602	380*	236.0M	Q3 FY26 10-QSep 30, 2026
Colgate Palmolive	1,527	5,369	1,171*	794.9M	Q3 FY26 10-QSep 30, 2026
Clorox	184	1,905	143	121.1M	Q1 FY27 10-QSep 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.